OneDraw A1C Test System

Assay, Glycosylated Hemoglobin

Drawbridge Health, Inc.

The following data is part of a premarket notification filed by Drawbridge Health, Inc. with the FDA for Onedraw A1c Test System.

Pre-market Notification Details

Device IDK183230
510k NumberK183230
Device Name:OneDraw A1C Test System
ClassificationAssay, Glycosylated Hemoglobin
Applicant Drawbridge Health, Inc. 11535 Sorrrento Valley Road, Suite 407 San Diego,  CA  92121
ContactAnnie Wright
CorrespondentAnnie Wright
Drawbridge Health, Inc. 11535 Sorrrento Valley Road, Suite 407 San Diego,  CA  92121
Product CodeLCP  
CFR Regulation Number864.7470 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2018-11-20
Decision Date2019-08-15

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00086303000046 K183230 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.